Literature DB >> 22074984

A novel caryophyllene type sesquiterpene lactone from Asparagus falcatus (Linn.); structure elucidation and anti-angiogenic activity on HUVECs.

Raza Murad Ghalib1, Rokiah Hashim, Othman Sulaiman, Sayed Hasan Mehdi, Arto Valkonen, Kari Rissanen, Srećko R Trifunović, Mohamed B Khadeer Ahamed, Amin Malik Shah Abdul Majid, Fumio Kawamura.   

Abstract

In this study the novel caryophyllene type sesquiterpene lactone (aspfalcolide) has been isolated from the leaves of Asparagus falcatus (Linn.) and characterized by IR, 1D NMR, 2D NMR, EI-MS, HR-ESI-MS and X-ray single crystal diffraction analysis. The aspfalcolide crystallizes in the orthorhombic space group P2(1)2(1)2(1) with a = 6.37360(10), b = 7.6890(2), c = 27.3281(6) Å, α = β = γ = 90(°) and Z = 4. One intermolecular O-H⋯O hydrogen bond enforces these natural molecules to form infinite chains through the crystal. Aspfalcolide was screened for its anti-angiogenic activity in human umbilical vein endothelial cells (HUVECs) and the result showed the remarkable inhibitory effect of aspfalcolide on the proliferation (IC(50) 1.82 μM), migration and tube formation of HUVECs.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22074984     DOI: 10.1016/j.ejmech.2011.10.037

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Punctaporonins H-M: caryophyllene-type sesquiterpenoids from the sponge-associated fungus Hansfordia sinuosae.

Authors:  Zehong Wu; Dong Liu; Peter Proksch; Peng Guo; Wenhan Lin
Journal:  Mar Drugs       Date:  2014-06-30       Impact factor: 5.118

2.  New Bioactive Sesquiterpeniods From the Plant Endophytic Fungus Pestalotiopsis theae.

Authors:  Gaoran Liu; Ruiyun Huo; Yanan Zhai; Ling Liu
Journal:  Front Microbiol       Date:  2021-03-31       Impact factor: 5.640

3.  In vitro antimicrobial activity of extracts from plants used traditionally in South Africa to treat tuberculosis and related symptoms.

Authors:  Balungile Madikizela; Ashwell Rungano Ndhlala; Jeffrey Franklin Finnie; Johannes Van Staden
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-05       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.